By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Renovacare 

430 Park Avenue
Suite 702
New York  New York  10022  U.S.A.
Phone: 888-398-0202 Fax: n/a


SEARCH JOBS

RenovaCare, Inc. is developing first-of-its-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the body’s largest organ, the skin. The company’s flagship technology, the CellMist™ System, uses its patented SkinGun™ to spray a liquid suspension of a patient’s stem cells – the CellMist™ Solution – onto wounds. RenovaCare is developing its CellMist™ System as a promising new alternative for patients suffering from burns, chronic and acute wounds, and scars. In the US alone, this $45 billion market is greater than the spending on high-blood pressure management, cholesterol treatments, and back pain therapeutics.

YEAR FOUNDED:

2013

LEADERSHIP:

President & CEO, CFO: Thomas Bold, MBA, Dipl-Kfm

Director of Operations: Drew Danielson

Director: Kenneth Kirkland, MS, PhD

Director: Joseph Sierchio, Esq.

VP, Regulatory & Clinical Affairs: Patsy Trisler, JD, RAC

Director of Cell Sciences: Roger Esteban-Vives, PhD

TECHNOLOGY:

Please click here for RenovaCare's technology.


Key Statistics


Email: info@renovacareinc.com
Ownership: Private

Web Site: Renovacare
Employees:
Symbol: 
 









Company News
//-->